Protective effect of ginseng polysaccharides on influenza viral infection

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Yoo, Dae Goon ^a,b   Kim, Min Chul ^a   Park, Min Kyung ^c,d   Park, Kyoung Mi ^a   Quan, Fu Shi ^e   Song, Jae Min ^c,f   Wee, Jae Joon ^g   Wang, Bao Zhong ^a   Cho, Young Keol ^h   Compans, Richard W ^a   Kang, Sang Moo ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

^d Chungwoon University   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

^f Sungshin Women's University   (South Korea)

^g Korea Ginseng Corporation   (South Korea)

^h University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENG POLYSACCHARIDE; INFLUENZA VACCINE; INTERLEUKIN 6; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; GINSENG; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LOW DRUG DOSE; MOUSE; NONHUMAN; SURVIVAL RATE; SUSPENSION; VIRUS STRAIN; ANIMAL; CHEMISTRY; DOG; ORTHOMYXOVIRUS INFECTION; PANAX;

MUS; ORTHOMYXOVIRIDAE; PANAX GINSENG;

ANIMALS; DOGS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; PANAX; POLYSACCHARIDES;

EID: 84863371358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033678     Document Type: Article

References (37)

1. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al. (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79: 2814-2822.
2. Solovyov A, Palacios G, Briese T, Lipkin WI, Rabadan R, (2009) Cluster analysis of the origins of the new influenza A(H1N1) virus. Euro Surveill 14 (21).
3. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
4. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460 (7258): 1021-1025.
5. Naffakh N, van der Werf S, (2009) April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect 11: 725-728.
6. Moscona A, (2005) Oseltamivir resistance-disabling our influenza defenses. N Engl J Med 353: 2633-2636.
7. Kim KH, Lee YS, Jung IS, Park SY, Chung HY, et al. (1998) Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 64: 110-115.
8. Lee YS, Chung IS, Lee IR, Kim KH, Hong WS, et al. (1997) Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 17: 323-331.
9. Han SK, Song JY, Yun YS, Yi SY, (2005) Ginsan improved Th1 immune response inhibited by gamma radiation. Arch Pharm Res 28: 343-350.
10. Song JY, Akhalaia M, Platonov A, Kim HD, Jung IS, et al. (2004) Effects of polysaccharide ginsan from Panax ginseng on liver function. Arch Pharm Res 27: 531-538.
11. Song JY, Han SK, Bae KG, Lim DS, Son SJ, et al. (2003) Radioprotective effects of ginsan, an immunomodulator. Radiat Res 159: 768-774.
12. Song JY, Han SK, Son EH, Pyo SN, Yun YS, et al. (2002) Induction of secretory and tumoricidal activities in peritoneal macrophages by ginsan. Int Immunopharmacol 2: 857-865.
13. Ernst E, (2010) Panax ginseng: An Overview of the Clinical Evidence. J Ginseng Res 34: 259-263.
14. Yuan CS, Wang CZ, Wicks SM, Qi LW, (2010) Chemical and pharmacological studies of saponins with a focus on American ginseng. Journal of ginseng research 34: 160-167.
15. Han Y, Son SJ, Akhalaia M, Platonov A, Son HJ, et al. (2005) Modulation of radiation-induced disturbances of antioxidant defense systems by ginsan. Evid Based Complement Alternat Med 2: 529-536.
16. Ahn JY, Choi IS, Shim JY, Yun EK, Yun YS, et al. (2006) The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol 36: 37-45.
17. Ahn JY, Song JY, Yun YS, Jeong G, Choi IS, (2006) Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol 46: 187-197.
18. Quan FS, Huang C, Compans RW, Kang SM, (2007) Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81: 3514-3524.
19. Lim YJ, Na HS, Yun YS, Choi IS, Oh JS, et al. (2009) Suppressive effects of ginsan on the development of allergic reaction in murine asthmatic model. Int Arch Allergy Immunol 150: 32-42.
20. Park JD, Shin HJ, Kwak YS, Wee JJ, Song YB, et al. (2006) Partial chemical structure and immunomodulating antitumor activities of RGAP (Red ginseng Acidic polysaccharide) from Korean red ginseng. The 9th International Symposium on Ginseng pp. 390-409.
21. Nakaya TA, Kita M, Kuriyama H, Iwakura Y, Imanishi J, (2004) Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J Interferon Cytokine Res 24: 93-100.
22. Quan FS, Compans RW, Nguyen HH, Kang SM, (2008) Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 82: 1350-1359.
23. Quan FS, Compans RW, Cho YK, Kang SM, (2007) Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine 25: 272-282.
24. Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, et al. (2010) Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol 84: 7760-7769.
25. Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, et al. (2008) A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 26: 3352-3361.
26. Rhule A, Navarro S, Smith JR, Shepherd DM, (2006) Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. J Ethnopharmacol 106: 121-128.
27. Shin JY, Song JY, Yun YS, Yang HO, Rhee DK, et al. (2002) Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol 24: 469-482.
28. Kim MH, Byon YY, Ko EJ, Song JY, Yun YS, et al. (2009) Immunomodulatory activity of ginsan, a polysaccharide of panax ginseng, on dendritic cells. Korean J Physiol Pharmacol 13: 169-173.
29. Tumpey TM, Lu X, Morken T, Zaki SR, Katz JM, (2000) Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 74: 6105-6116.
30. Maruoka S, Hashimoto S, Gon Y, Nishitoh H, Takeshita I, et al. (2003) ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem Biophys Res Commun 307: 870-876.
31. Mok CK, Lee DC, Cheung CY, Peiris M, Lau AS, (2007) Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 88: 1275-1280.
32. Schultz-Cherry S, Dybdahl-Sissoko N, Neumann G, Kawaoka Y, Hinshaw VS, (2001) Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol 75: 7875-7881.
33. Brydon EW, Morris SJ, Sweet C, (2005) Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiol Rev 29: 837-850.
34. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, et al. (2006) The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15: 1894-1913.
35. Chen PY, Sun JS, Tsuang YH, Chen MH, Weng PW, et al. (2010) Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Nutr Res 30: 191-199.
36. Lim TS, Na K, Choi EM, Chung JY, Hwang JK, (2004) Immunomodulating activities of polysaccharides isolated from Panax ginseng. J Med Food 7: 1-6.
37. Lu ZQ, Dice JF, (1985) Ginseng extract inhibits protein degradation and stimulates protein synthesis in human fibroblasts. Biochem Biophys Res Commun 126: 636-640.